Secukinumab effect on the severity of ankylosing spondylitis after 5 years
A simplified overview of the abstract presented November 6, 2020.
Secukinumab as a treatment for psoriatic arthritis predominantly affecting the joints of the back and neck (axial joints)
A simplified overview of the abstract presented November 6, 2020.
Using sensitive ultrasound imaging to understand speed of secukinumab response in psoriatic arthritis
A simplified overview of the abstract presented November 8, 2020.
Using machine learning to predict likelihood of achieving relief from psoriatic arthritis
A simplified overview of the abstract presented November 9, 2020.